Wikidata

(Q113909506)

English

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

clinical trial

In more languages

Statements

title
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 160 in Subjects With Non-Small Cell Lung Cancer (English)
0 references
country
Australia
0 references
Austria
0 references
start time
31 August 2021
0 references
end time
19 June 2026
0 references
number of participants
50
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113909506&oldid=2149017782"